Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilonacept in Familial Mediterranean Fever
NCT00582907Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Aug 2008
- Primary completion
- Sep 2011
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of rilonacept in Familial Mediterranean fever (FMF), sponsored by Cleveland Clinic. Started Aug 2008; status: completed.
02
Drugs
rilonacept
03
Conditions
Familial Mediterranean fever (FMF)
Beyond the preview
Go deeper on NCT00582907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00582907.